ASMB

MKT CAP:$533M

Assembly Biosciences Inc

Market Cap

$533M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$22.90-$10.85 (-32.15%)

Jun 5, 2026

52W High $38.5052W Low $16.07

Company Details

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, w...

CEO

—

IPO Date

Dec 17, 2010

Website

www.assemblybio.com

Key Metrics TTM

Revenue

$71M

+121.1% YoY

Net Income

-$6M

EPS (Diluted)

Free Cash Flow

-$40M

Revenue / Share

$4.21

Gross Margin

77.2%

Operating Margin

-19.1%

Net Margin

-9.0%

FCF Margin

-56.0%

P/S

7.5x

P/E

Earnings Reports

Q1 2026

May 7, 2026

$8M-12.8%

FY 2025

Mar 19, 2026

$72M+153.5%

Q4 2025

Mar 19, 2026

$42M+477.3%

Q3 2025

Nov 10, 2025

$11M+57.6%

Q2 2025

Aug 6, 2025

$10M+12.8%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee